Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation

AGID¹

April 2012

Diagnostic clues from the history could include a personal or family history of autoimmunity or cancer. Oncological associations have been seen in a paraneoplastic context in patients with autoimmune gastrointestinal dysmotility and these include carcinomas (usually of the lung), breast, endometrium or GI system, and sometimes thymoma.

< Previous Slide

AGID1

Next Slide >

 

Jump to section:

• Introduction
• New Profile
• AGID
• Symptoms
• AGID¹
• AGID^1,2
• AGID: Laboratory Findings
• AGID: Antibody Evaluation
• Ganglionic Acetylcholine Receptor (AChR) Autoantibody^3,4
• Ganglionic AChR Autoantibody
• AGID Antibody Profile
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• Clinical Utility of AGID Evaluation
• Clinical Utility of AGID Evaluation
• Summary
• References
• Questions